Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


2 Anticancer Res
1 Appl Immunohistochem Mol Morphol
1 Biomaterials
1 Cancer Med
2 Clin Cancer Res
1 Clin Nucl Med
1 Clinicoecon Outcomes Res
1 DNA Cell Biol
1 Drugs Today (Barc)
1 Epidemiology
1 Eur Rev Med Pharmacol Sci
6 Eur Urol Focus
1 Georgian Med News
1 Int Braz J Urol
1 Int J Mol Sci
2 Int Urol Nephrol
1 Mar Drugs
1 Neoplasia
2 Oncotarget
1 Open Forum Infect Dis
1 PLoS One
1 Urol Clin North Am
1 Urol Oncol
1 World J Surg Oncol

    Anticancer Res

  1. ZHOU HH, Liu LY, Yu GH, Qu GM, et al
    Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Anticancer Res. 2017;37:4529-4537.
    >> Share

  2. DU P, Wang S, Tang X, An C, et al
    Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Anticancer Res. 2017;37:4499-4505.
    >> Share

    Appl Immunohistochem Mol Morphol

  3. SEDAGHAT S, Gheytanchi E, Asgari M, Roudi R, et al
    Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.
    Appl Immunohistochem Mol Morphol. 2017;25:196-202.
    >> Share


  4. PAVAN GRANDHI TS, Potta T, Nitiyanandan R, Deshpande I, et al
    Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation.
    Biomaterials. 2017;142:171-185.
    >> Share

    Cancer Med

  5. SAHU D, Lotan Y, Wittmann B, Neri B, et al
    Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
    Cancer Med. 2017 Aug 1. doi: 10.1002/cam4.1109.
    >> Share

    Clin Cancer Res

  6. WEN T, Yang Z, He L, Lin K, et al
    The KMT1A-GATA3-STAT3 circuit is a novel self-renewal signaling of human bladder cancer stem cells.
    Clin Cancer Res. 2017 Aug 1. pii: clincanres.0882.2017.
    >> Share

  7. VANDEKERKHOVE GR, Todenhofer T, Annala M, Struss WJ, et al
    <span style="font-weight: 400;">Circulating tumor DNA reveals clinically-actionable somatic genome of metastatic bladder cancer</span>.
    Clin Cancer Res. 2017 Jul 31. pii: clincanres.1140.2017.
    >> Share

    Clin Nucl Med

  8. YOON HJ, Yoo J, Kim Y, Lee DH, et al
    Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol.
    Clin Nucl Med. 2017 Jul 29. doi: 10.1097/RLU.0000000000001780.
    >> Share

    Clinicoecon Outcomes Res

  9. GERACE C, Montorsi F, Tambaro R, Carteni G, et al
    Cost of illness of urothelial bladder cancer in Italy.
    Clinicoecon Outcomes Res. 2017;9:433-442.
    >> Share

    DNA Cell Biol

  10. HU R, Zhong P, Xiong L, Duan L, et al
    Long Noncoding RNA Cancer Susceptibility Candidate 8 Suppresses the Proliferation of Bladder Cancer Cells via Regulating Glycolysis.
    DNA Cell Biol. 2017 Jul 31. doi: 10.1089/dna.2017.3785.
    >> Share

    Drugs Today (Barc)

    Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers.
    Drugs Today (Barc). 2017;53:217-237.
    >> Share


  12. LOFTFIELD E, Freedman ND, Inoue-Choi M, Graubard BI, et al
    A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States.
    Epidemiology. 2017;28:685-693.
    >> Share

    Eur Rev Med Pharmacol Sci

  13. LIU H, Chang JK, Hou JQ, Zhao ZH, et al
    Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Eur Rev Med Pharmacol Sci. 2017;21:3193-3199.
    >> Share

    Eur Urol Focus

  14. VIND-KEZUNOVIC S, Bouchelouche K, Ipsen P, Hoyer S, et al
    Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.
    Eur Urol Focus. 2017 Jun 23. pii: S2405-4569(17)30156.
    >> Share

  15. KRAMER MW, Altieri V, Hurle R, Lusuardi L, et al
    Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer: Update 2016.
    Eur Urol Focus. 2017 Jan 11. pii: S2405-4569(16)30180.
    >> Share

  16. KUKREJA JB, Porten S, Golla V, Ho PL, et al
    Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Eur Urol Focus. 2017 Jan 18. pii: S2405-4569(16)30181.
    >> Share

  17. NASELLI A, Hurle R, Paparella S, Buffi NM, et al
    Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2017 Jan 13. pii: S2405-4569(17)30006.
    >> Share

  18. NECCHI A, Mariani L, Lo Vullo S, Yu EY, et al
    Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
    Eur Urol Focus. 2017 Jun 3. pii: S2405-4569(17)30125.
    >> Share

  19. NECCHI A, Pond GR, Smaldone MC, Pal SK, et al
    Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
    Eur Urol Focus. 2017 Mar 31. pii: S2405-4569(17)30079.
    >> Share

    Georgian Med News

    Georgian Med News. 2017;:29-35.
    >> Share

    Int Braz J Urol

  21. XING NZ, Kang N, Song LM, Niu YN, et al
    Laparoscopic radical cystectomy with novel orthotopic neobladder with bilateral isoperistaltic afferent limbs: initial experience.
    Int Braz J Urol. 2017;43:57-66.
    >> Share

    Int J Mol Sci

  22. HUANG SY, Chang SF, Liao KF, Chiu SC, et al
    Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Int J Mol Sci. 2017;18.
    >> Share

    Int Urol Nephrol

  23. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Int Urol Nephrol. 2017;49:233-238.
    >> Share

  24. SONG W, Jeon HG, Jeong BC, Seo SI, et al
    Clinical significance of incidentally detected bladder wall thickening on computed tomography.
    Int Urol Nephrol. 2017;49:191-196.
    >> Share

    Mar Drugs

  25. CHENG TC, Din ZH, Su JH, Wu YJ, et al
    Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.
    Mar Drugs. 2017;15.
    >> Share


  26. ZHU J, Li Y, Chen C, Ma J, et al
    NF-kappaB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIalpha Protein.
    Neoplasia. 2017;19:672-683.
    >> Share


  27. MA Y, Luo W, Bunch BL, Pratt RN, et al
    1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.
    Oncotarget. 2017 Jul 27. doi: 10.18632/oncotarget.19629.
    >> Share

  28. AZEVEDO R, Peixoto A, Gaiteiro C, Fernandes E, et al
    Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
    Oncotarget. 2017 Jul 21. doi: 10.18632/oncotarget.19433.
    >> Share

    Open Forum Infect Dis

  29. RACHAKONDA T, Kendall B, Spivak AM, Boltax J, et al
    Pleural Effusion Caused by Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer.
    Open Forum Infect Dis. 2017;4:ofx126.
    >> Share

    PLoS One

  30. SU YL, Hsieh MC, Chiang PH, Sung MT, et al
    Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma.
    PLoS One. 2017;12:e0169657.
    >> Share

    Urol Clin North Am

  31. DRAY EV, Cameron AP
    Identifying Patients with High-Risk Neurogenic Bladder: Beyond Detrusor Leak Point Pressure.
    Urol Clin North Am. 2017;44:441-452.
    >> Share

    Urol Oncol

  32. PACKIAM VT, Lamm DL, Barocas DA, Trainer A, et al
    An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results.
    Urol Oncol. 2017 Jul 26. pii: S1078-1439(17)30350.
    >> Share

    World J Surg Oncol

  33. SHI HB, Yu JX, Yu JX, Feng Z, et al
    Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
    World J Surg Oncol. 2017;15:147.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016